Trending Stories
Focus on Transplantation
Outcomes among Transplant Recipients Hospitalized Due to COVID-19
Due to chronic immunosuppression as well as the presence of numerous comorbidities, the risk of developing severe COVID-19 may be high in kidney transplant...
Elevated dd-cfDNA Levels to Monitor Patients with Delayed Graft Function
American Society of Transplant Surgeons Winter Symposium
Among recipients of deceased donor kidney transplants, approximately 31% are affected by delayed graft function; in 2% of...
Monitoring Dual and en Bloc Kidney Transplant Patients for Allograft Rejection
American Society of Transplant Surgeons Winter Symposium 2021
End-stage kidney disease is commonly treated with kidney transplantation. However, the number of patients on the waitlist...
Anti-Rejection Therapies May Influence Total cfDNA Levels
American Society of Transplant Surgeons Winter Symposium 2021
To prevent rejection, recipients of organ transplants initiate a regimen of immunosuppressive medications. Modulation of immunosuppressants to...
Monitoring Allograft Rejection with dd-cfDNA Testing
American Society of Transplant Surgeons Winter Symposium 2021
The current gold standard for diagnosis of allograft rejection is biopsy. However, access to biopsy services is...